Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "amgen rank"

#1 Rank Bull of the Day Amgen (AMGN)
Zacks.com

#1 Rank Bull of the Day Amgen (AMGN)

Biotechnology has been an extremely hot industry thanks to high demand for the sector and new drugs which are boosting revenues across the board. The space also generally has a pretty good pipeline of drugs that are ready to come on the market over ... Zacks.com, 1 week ago
Bull of the Day: Amgen (AMGN) - Bull of the Day Yahoo! Finance, 1 week ago
Zacks' Bull Of The Day: Amgen Seeking Alpha, 1 week ago

2 images for "amgen rank"

Forbes.com, 3 weeks ago
Forbes.com, 3 weeks ago

Amgen Upgraded to Strong Buy; is it in Your Portfolio? - Analyst Blog

On Jan 3, Zacks Investment Research upgraded Amgen Inc. ( AMGN ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Amgen came out with strong third quarter results and an improved outlook for 2014 on Oct 27. The biotech company's earnings ...
 Zacks.com3 weeks ago
Forbes.com

Amgen Moves Up In Market Cap Rank, Passing Schlumberger

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Amgen Inc (AMGN) has taken over the #36 spot from Schlumberger Ltd. (SLB), according to The
 Vision Monday3 weeks ago
[x]  

Amgen (AMGN) Trading Near $157.60 Support Level

The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Amgen Inc (http://www.marketintelligencecenter.com/symbol/AMGN"AMGN) that should provide a 5.49% return in just 53 days. Sell one ...
 Individual.com1 day ago Amgen (AMGN) Trading Near $162.71 Resistance Level  PredictWallStreet1 week ago Amgen (AMGN) Trading Near $151.94 Support Level  TradingCharts.com3 weeks ago Amgen (AMGN) Trading Near $166.92 Resistance Level  TradingCharts.com1 month ago

Amgen (AMGN) Showing Bearish Technicals With Resistance At $162.41

Amgen Inc (http://www.marketintelligencecenter.com/symbol/AMGN"AMGN) closed Tuesday at $157.60 and technical indicators recently have been bearish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a ...
 Individual.com6 days ago
State Of The Markets.com

Chart of the Day: Amgen Inc, 1/26/15

If you enjoy the Chart of the Day be sure to check out SoTM's new, *FREE* Trade of the Day product on our Premium Services page. The Trade of the Day gives an in depth swing-trading set-up each and every day, including long and short ideas! ...
 State Of The Markets.com1 day ago Amgen, Rio Tinto, Intel, IBM and Cisco highlighted as Zacks Bull and Bear of the Day - Press Release …  Yahoo! Finance1 week ago MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day  Tamar Securities1 month ago
[x]  

Potential Amgen (AMGN) Trade Has 3.26% Downside Protection

After ThursdayaEUR(TM)s trading in Amgen Inc (http://www.marketintelligencecenter.com/symbol/AMGN"AMGN) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 8.87% return or 35.56% on an annualized basis (for comparison ...
 Individual.com1 week ago Potential Amgen (AMGN) Trade Has 2.46% Downside Protection  TradingCharts.com4 weeks ago Potential Amgen (AMGN) Trade Targets 6.03% Return  TradingCharts.com1 month ago

Amgen Maintains 2015 View, Expects Several Drug Launches - Analyst Blog

At the J.P. Morgan (JPM) 33rd annual healthcare conference, Amgen (AMGN) said that it is maintaining its 2015 revenue guidance, provided in October last year, of $20.8 billion to $21.3 billion. Revenues, as per the Zacks Consensus Estimate, ...
 Yahoo! Finance1 week ago

The Zacks Analyst Blog Highlights: Kite Pharma, Isis Pharmaceuticals, Alkermes, Amgen and Biogen - Press …

For Immediate Release Chicago, IL January 08, 2015 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial ...
 Yahoo! Finance2 weeks ago The Zacks Analyst Blog Highlights:Cubist Pharmaceuticals, bluebird bio, Amgen, Incyte and Array  Individual.com1 month ago
[x]  

Amgen receives FDA approval for new indication of XGEVA for treatment of HCM

Amgen Inc., a biotechnology company, has received the FDA approval for a new indication for XGEVA for the treatment of hypercalcemia of malignancy, or HCM, refractory to bisphosphonate therapy. XGEVA was approved and granted Orphan Drug Designation ...
 Individual.com3 weeks ago 12/28/14 - FDA Approves Amgen's XGEVA® Denosumab For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy  Pharmacy Choice4 weeks ago FDA Approves Amgen's XGEVA® Denosumab For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy  4 Traders1 month ago Amgen's Xgeva gets US FDA approval to treat hypercalcemia of malignancy refractory to bisphosphonate therapy  PharmaBiz1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less